Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein

NCT01793818 is registered in ClinicalTrials.gov with BIOSANTECH as lead sponsor.

NCT NCT01793818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein
Lead sponsor
BIOSANTECH
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 28, 2013
Completion date
March 31, 2016
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids